E. Fernández

Antiatherosclerotic Effect of an Antibody That Binds to Extracellular Matrix Glycosaminoglycans

Y. Fernández-Marrero, A. López-Requena, V. Falcón, 2012, Arteriosclerosis, thrombosis, and vascular biology.

Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients.

J. Koropatnick, R. Figueredo, A. Lage, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Biodistribution of 99mTc-labeled anti-human epidermal growth factor receptor (EGF-R) humanized monoclonal antibody h-R3 in a xenograft model of human lung adenocarcinoma.

N. Iznaga-Escobar, J. Duconge, E. Fernández, 1999, Nuclear medicine and biology.

Pharmacokinetics, biodistribution and dosimetry of 99mTc-labeled anti-human epidermal growth factor receptor humanized monoclonal antibody R3 in rats.

J. Duconge, J. A. Gómez, I. C. Torres, 1998, Nuclear medicine and biology.

Freeze-dried formulation for direct 99mTc-labeling ior-egf/r3 MAb: additives, biodistribution, and stability.

N. Iznaga-Escobar, J. Duconge, A. Morales, 1999, Nuclear medicine and biology.

Humanized versus murine anti-human epidermal growth factor receptor monoclonal antibodies for immunoscintigraphic studies.

N. Iznaga-Escobar, J. Duconge, A. Morales, 2000, Nuclear medicine and biology.

Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor.

A. Lage, T. Crombet, M. Catalá, 2001, Cancer biotherapy & radiopharmaceuticals.

Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers.

V. Besada, G. Padrón, G. Guillén, 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Freeze-dried formulation for the direct 99mTc-labeling of ior egf/r3 monoclonal antibody: equivalence studies

J. Duconge, N. Pérez, E. Fernández, 2000 .

Increased bioavailability of IFN a 2 b modificed by chemical conjugation to a two-branched polyethyleneglycol molecule

P. López-Saura, I. García, C. Peniche, 2016 .

Integrative Physiology/Experimental Medicine Antiatherosclerotic Effect of an Antibody That Binds to Extracellular Matrix Glycosaminoglycans

A. López-Requena, V. Falcón, E. Acosta, 2012 .